About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Global Market Director & Global Product Manager (Oct 2011 – Present); Denmark
The precision fermentation market, including plant-based foods, is rapidly growing with a 40-46% CAGR, driven by consumer health awareness, ethical production, sustainability goals, and technological innovation globally.
Senior Lead of Physical Therapy (Jul 2025 – Present)
Dry needling is increasingly integrated into clinical workflows with rising use among elite athletes, becoming a standard in high-performance rehab. Demand grows in GCC and Asia, driven by sports injury rehabilitation and government investments in sports medicine.
Co-Founder
The global AI-driven drug discovery market, valued at $1.7–6.3B in 2024, is projected to grow to $8.5–16.5B by 2030–2034, led by oncology. AI reduces R&D costs by up to 70%, accelerates timelines by 1–2 years, and improves success rates. Breakthroughs include generative AI, foundation models, and au
Assistant General Manager (Feb 2020 – Present)
The mRNA revolution is reshaping vaccine scalability, cost, and efficacy, with strong pipeline momentum in therapeutics. Advances in delivery and stability drive adoption, while firms tackle CMC, manufacturing scale-up, and regulatory hurdles.
Founder (Dec 2023 – Present)
U.S. healthcare consolidation targets behavioral health, outpatient care; AI-driven RCM innovations cut costs; platform integration gains traction among mid-sized providers.
Regional GCC Head (Oct 2024 – Present)
Digital transformation is revolutionizing pharma’s commercial and operational functions through e-health, telemedicine, and AI-driven R&D. Pharma markets show steady 6–8% growth with rising demand for retail over hospital products. Biosimilars, injectables, and digital health dominate growth opportu